Silk Road Medical Inc Quarterly Return On Equity in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Silk Road Medical Inc quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q2 2024.
  • Silk Road Medical Inc Return On Equity for the quarter ending June 30, 2024 was -37.3 %, a 5.78% increase year-over-year.
  • Silk Road Medical Inc annual Return On Equity for 2023 was -36.1 %, a 42.8% increase from 2022.
  • Silk Road Medical Inc annual Return On Equity for 2022 was -63.1 %, a 15.5% decline from 2021.
  • Silk Road Medical Inc annual Return On Equity for 2021 was -54.6 %, a 20.6% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -37.3 +2.29 +5.78% Apr 1, 2024 Jun 30, 2024
Q1 2024 -35.2 +14.8 +29.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -36.1 +27 +42.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -35.1 +51.3 +59.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -39.6 +42.6 +51.8% Apr 1, 2023 Jun 30, 2023
Q1 2023 -50 +17.4 +25.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -63.1 -8.45 -15.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -86.4 -33.6 -63.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -82.2 -36.7 -80.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -67.4 -25.1 -59.4% Jan 1, 2022 Mar 31, 2022
Q4 2021 -54.6 -9.34 -20.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -52.8 -12.1 -29.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -45.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -42.3 Jan 1, 2021 Mar 31, 2021
Q4 2020 -45.3 Oct 1, 2020 Dec 31, 2020
Q3 2020 -40.7 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.